A never-before line-up of over 80 Speakers from international pharma, MNCs in China, and domestic Chinese pharma/biotechs will be sharing their expert opinions and experiences on transformation & innovation in China, clinical challenges, regulatory updates , NCE discovery efforts, preclinical partnerships, biosimilars development and more!
Plenary Sessions and Overall Program
Steve Yang, Ph.D., Vice President, Head of R&D, Asia, Pfizer Global Research & Development
Tony Zhang, Ph.D., Vice President, Global External R&D, Asia, Eli Lilly & Co.
Xian-Ping Lu, Ph.D., CEO & Chief Scientific Officer, Shenzhen Chipscreen Biosciences, Ltd.
Kewen Jin, M.D., General Manager, Preclinical Services, Charles River Laboratories Greater China
Li Chen, Ph.D., Chief Executive Officer, Hua Medicine
Clinical & Regulatory Summit
-- Ruiping Dong, M.D., Ph.D., Senior Vice President, Head of Emerging Markets R&D, Merck Research Laboratories
-- Maria Song, Ph.D., M.D., R. Pharmacist, M.A., President, VPS-CRO Group
-- Ling Su, Ph.D., Senior Vice President, Head of Development Greater China, Novartis Pharma
-- Karen Atkin, M.D., Vice President, R&D, AstraZeneca China
-- Li Ding, MSc., China Site Head, Clinical Data Management, Sanofi-aventis
-- Frank Shen, Ph.D., Head, Biometrics (Biostatistics & Data Management), Actemra China Development Champion, Roche Global Pharma Development Center, Asia Pacific
-- Dan Zhang, M.D., MPH, Co-Founder & CEO, Fountain Medical Development
AND MANY MORE!